The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck).
暂无分享，去创建一个
R. Walter | A. Evdokimov | A. Gołębiowski | T. A. Brugel | John C Vanrens | V. Easwaran | M. J. Janusz | M. J. Laufersweiler | M. Sabat | J. C. Vanrens | B. De | L. Hsieh | Jennifer A. Maier | M. Mekel | Mark Sabat | Todd A. Brugel